Aura Biosciences, Inc. (AURA) · INSIDERData sourcesSEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago
Public companyAura Biosciences, Inc.
AURACIK 0001501796
Price$7.25
1 year+28.1%
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score13
Connections with evidence6
AURA · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 9 | KEKratz EricaChief Reg. & Quality Officer | AURAAura Biosciences, Inc. Grant or award | A | — 100.9K sh | Sep 1, 2026 | Sep 1, 2026 |
| 9 | HJHopkins Janet JillChief Medical Officer | AURAAura Biosciences, Inc. Grant or award | A | — 116.2K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 9 | ASAbu-Absi SusanChief Operating Officer | AURAAura Biosciences, Inc. Grant or award | A | — 134.5K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 13 | EAElazzouzi AmySVP, Finance & PAO | AURAAura Biosciences, Inc. Grant or award | A | — 23.5K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 13 | HJHopkins Janet JillChief Medical Officer | AURAAura Biosciences, Inc. Grant or award | A | — 58.9K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 9 | KEKratz EricaChief Reg. & Quality Officer | AURAAura Biosciences, Inc. Grant or award | A | — 199.1K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 9 | ASAbu-Absi SusanChief Operating Officer | AURAAura Biosciences, Inc. Grant or award | A | — 265.5K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 9 | PJPerson JulieChief People Officer | AURAAura Biosciences, Inc. Grant or award | A | — 212.4K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 9 | EAElazzouzi AmySVP, Finance & PAO | AURAAura Biosciences, Inc. Grant or award | A | — 46.5K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
| 9 | PJPerson JulieChief People Officer | AURAAura Biosciences, Inc. Grant or award | A | — 107.6K sh | Sep 1, 2026 | Sep 1, 2026 traded Sep 1, 2026 | +0d | SEC Form 4 | |
Chief Medical Officer · Sep 1, 2026